TELA Bio, Inc. (TELA) › Shareholders' EquityTELA Bio, Inc. (TELA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2016: -$81.17M2017: -$108.17M2018: -$137.86M2019: $30.96M2020: $49.03M2021: $20.10M2022: $14.30M2023: $18.88M2024: $28.46M2025: $6.31M$6.31M2016Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$6.31M-77.8%2024$28.46M+50.7%2023$18.88M+32.0%2022$14.30M-28.8%2021$20.10M-59.0%2020$49.03M+58.3%2019$30.96M+122.5%2018-$137.86M-27.4%2017-$108.17M-33.3%2016-$81.17M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share